Immunology Leader Vincenzo Cerundolo Dies
Immunology Leader Vincenzo Cerundolo Dies
The Oxford researcher’s work on lipid and peptide antigens revealed key mechanisms in inflammation, immunotherapy, and vaccination, which are being pursued in clinical trial treatments.
Immunology Leader Vincenzo Cerundolo Dies
Immunology Leader Vincenzo Cerundolo Dies

The Oxford researcher’s work on lipid and peptide antigens revealed key mechanisms in inflammation, immunotherapy, and vaccination, which are being pursued in clinical trial treatments.

The Oxford researcher’s work on lipid and peptide antigens revealed key mechanisms in inflammation, immunotherapy, and vaccination, which are being pursued in clinical trial treatments.

MHC molecules
Infographic: Targeting Cancer Antigens
Infographic: Targeting Cancer Antigens
Stephen P. Schoenberger and Ezra Cohen | Mar 31, 2017
Neoantigens may serve as valuable targets for new immunotherapies.
Second Contagious Cancer Found in Tasmanian Devils
Second Contagious Cancer Found in Tasmanian Devils
Anna Azvolinsky | Dec 29, 2015
A second fatal, transmissible cancer has been identified in the already endangered species.  
Poor Little Devils
Poor Little Devils
Jesse Jenkins | Oct 31, 2014
See the devastating infectious cancer that may drive the Tasmanian Devil to extinction.
The Devil’s Details
The Devil’s Details
Jesse Jenkins | Oct 31, 2014
With the iconic Australian marsupial carnivore on the brink of extinction, Tasmanian researchers race to unlock the immunological mysteries of a disease threatening the species.
Beyond Expectation
Karen Hopkin | Aug 31, 2011
Philippa “Pippa” Marrack has made some unanticipated discoveries about how the immune system functions in health and disease.
Baruj Benacerraf Dies
Edyta Zielinska | Aug 3, 2011
The Nobel Prize winner who discovered the gene that encodes the major histocompatibility complex passes away at age 90.
Thymus Finder
Richard P. Grant | Jun 30, 2011
Editor’s Choice in Immunology
Foresight
Karen Hopkin | Jun 30, 2011
Studying the earliest events in visual development, Carla Shatz has learned the importance of looking at one’s data with open eyes—and an open mind.